Abiopharma

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Compugen - Compugen Reports Third Quarter 2025 Results

Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests

908 Devices Inc. - 908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025

CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025

Galecto Announces Acquisition of Damora Therapeutics

Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody

Immunocore to present at upcoming investor conferences